XML 33 R18.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Share-based Compensation | 12 Months Ended
--- | ---
Dec. 31, 2024
Equity [Abstract] |
Share-based Compensation | Note 6 - Share-based Compensation Stock Options The fair value of each option award is estimated on the date of grant using a Black Scholes option valuation model that uses the assumptions noted in the following table. Because Black Scholes option valuation models incorporate ranges of assumptions for inputs, these ranges are disclosed. Expected volatilities and based on implied volatilities from traded options on the Company’s stock, historical volatility of the Company’s stock, and other factors. The expected term of options granted is derived from the output of the valuation model and represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.
Schedule of assumptions |  |  |  |
|  | December 31, 2024 |  | December 31, 2023
Per share fair value at grant date |  |  | $0.42 - $88.85 |  |  |  | $5.68 - $88.85 |
Risk-free interest rate |  |  | 0.9% - 272% |  |  |  | 0.9% - 272% |
Expected volatility |  |  | 77.04% – 10,900% |  |  |  | 77.04% - 10,900% |
Dividend yield |  |  | 0% |  |  |  | 0% |
Expected life in years |  |  | 5.0 – 6.4 |  |  |  | 5.24 – 6.38 |
The following table presents the activity for stock options outstanding:
Schedule of stock option activity |  |  |  |  |  |
|  | Options |  |  | Weighted Average Exercise Price |
Outstanding - December 31, 2022 |  |  | 66,527 |  |  | $ | 61.13 |
Granted |  |  | 26,726 |  |  |  | 11.42 |
Forfeited/canceled |  |  | (8,358 | ) |  |  | 37.76 |
Exercised |  |  | – |  |  |  | – |
Outstanding - December 31, 2023 |  |  | 84,895 |  |  |  | 47.79 |
Granted |  |  | 500,000 |  |  |  | 0.51 |
Forfeited/canceled |  |  | (1,493 | ) |  |  | 58.39 |
Exercised |  |  | – |  |  |  | – |
Outstanding - December 31, 2024 |  |  | 583,402 |  |  | $ | 7.24 |
The following table presents the composition of options outstanding and exercisable:
Schedule of options outstanding and exercisable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
|  | Options Outstanding** |  |  | Options Exercisable** |
Exercise Prices |  | Number |  |  | Price |  |  | Life* |  |  | Number |  |  | Price* |
$0.51 |  |  | 500,000 |  |  | $ | 0.51 |  |  |  | 10.00 |  |  |  | 500,000 |  |  | $ | 0.51 |
$72.39 |  |  | 2,131 |  |  | $ | 72.39 |  |  |  | 2.86 |  |  |  | 2,131 |  |  | $ | 72.39 |
$106.50 |  |  | 6,853 |  |  | $ | 106.50 |  |  |  | 4.48 |  |  |  | 6,853 |  |  | $ | 106.50 |
$69.75 |  |  | 30,891 |  |  | $ | 69.75 |  |  |  | 5.97 |  |  |  | 29,041 |  |  | $ | 69.75 |
$44.75 |  |  | 7,250 |  |  | $ | 44.75 |  |  |  | 6.67 |  |  |  | 5,562 |  |  | $ | 44.75 |
$30.25 |  |  | 15,577 |  |  | $ | 30.25 |  |  |  | 7.69 |  |  |  | 15,577 |  |  | $ | 30.25 |
$9.90 |  |  | 2,000 |  |  | $ | 9.90 |  |  |  | 8.44 |  |  |  | 500 |  |  | $ | 9.90 |
$6.25 |  |  | 18,700 |  |  | $ | 6.25 |  |  |  | 8.95 |  |  |  | 2,750 |  |  | $ | 6.25 |
Total - December 31, 2024 |  |  | 583,402 |  |  |  |  |  |  |  |  |  |  |  | 562,414 |  |  |  |  |
________________________
* | Price and Life reflect the weighted average exercise price and weighted average remaining contractual life, respectively.
** | The Company’s options summarized above have been retroactively restated for the effect of the 25-for-1 reverse stock split.
Restricted Stock Units The following table presents the activity for restricted stock units outstanding:
Schedule of restricted stock units outstanding |  |  |  |  |  |  |  |
|  | Restricted Stock Units |  |  | Weighted Average Grant Date Fair Value |
Outstanding - December 31, 2022 |  |  | 22,554 |  |  | $ | 53.61 |
Granted |  |  | 1,500 |  |  |  | 31.00 |
Forfeited/canceled |  |  | (4,734 | ) |  |  | 45.66 |
Exercised |  |  | (7,830 | ) |  |  | 45.66 |
Outstanding - December 31, 2023 |  |  | 11,490 |  |  |  | 59.36 |
Granted |  |  | – |  |  |  | – |
Forfeited/canceled |  |  | (500 | ) |  |  | – |
Exercised |  |  | (6,245 | ) |  |  | 61.74 |
Outstanding - December 31, 2024 |  |  | 4,745 |  |  | $ | 56.52 |
The Company recognized share-based compensation expense related to stock options and restricted stock units of $736,797 and $1,025,420 for the years ended December 31, 2024 and 2023, respectively. The remaining unvested share-based compensation expense of $181,805 is expected to be recognized over the next 36 months.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration